
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of a selective inhibitor of doublecortin like kinase 1
Fleur M. Ferguson, Behnam Nabet, Srivatsan Raghavan, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 6, pp. 635-643
Open Access | Times Cited: 98
Fleur M. Ferguson, Behnam Nabet, Srivatsan Raghavan, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 6, pp. 635-643
Open Access | Times Cited: 98
Showing 1-25 of 98 citing articles:
An atlas of substrate specificities for the human serine/threonine kinome
Jared L. Johnson, Tomer M. Yaron, Emily M. Huntsman, et al.
Nature (2023) Vol. 613, Iss. 7945, pp. 759-766
Open Access | Times Cited: 375
Jared L. Johnson, Tomer M. Yaron, Emily M. Huntsman, et al.
Nature (2023) Vol. 613, Iss. 7945, pp. 759-766
Open Access | Times Cited: 375
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
Behnam Nabet, Fleur M. Ferguson, Bo Kyung A. Seong, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 210
Behnam Nabet, Fleur M. Ferguson, Bo Kyung A. Seong, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 210
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis
Edoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Science (2021) Vol. 373, Iss. 6561
Open Access | Times Cited: 160
Edoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Science (2021) Vol. 373, Iss. 6561
Open Access | Times Cited: 160
Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
Christopher Arter, Luke Trask, Sarah Ward, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 8, pp. 102247-102247
Open Access | Times Cited: 103
Christopher Arter, Luke Trask, Sarah Ward, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 8, pp. 102247-102247
Open Access | Times Cited: 103
Identification of a potent and selective covalent Pin1 inhibitor
Benika J. Pinch, Zainab M. Doctor, Behnam Nabet, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 9, pp. 979-987
Open Access | Times Cited: 75
Benika J. Pinch, Zainab M. Doctor, Behnam Nabet, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 9, pp. 979-987
Open Access | Times Cited: 75
A pan-cancer organoid platform for precision medicine
Brian M. Larsen, Madhavi Kannan, Lee Langer, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109429-109429
Open Access | Times Cited: 74
Brian M. Larsen, Madhavi Kannan, Lee Langer, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109429-109429
Open Access | Times Cited: 74
Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness
Rui Yan, Xiaona Fan, Zeru Xiao, et al.
Cancer Letters (2022) Vol. 531, pp. 83-97
Open Access | Times Cited: 43
Rui Yan, Xiaona Fan, Zeru Xiao, et al.
Cancer Letters (2022) Vol. 531, pp. 83-97
Open Access | Times Cited: 43
Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses
Zhuqi Huang, Sirui Shen, Xue Han, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 5
Open Access | Times Cited: 27
Zhuqi Huang, Sirui Shen, Xue Han, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 5
Open Access | Times Cited: 27
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs
Qi Zhao, Hong Zong, Pingping Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Qi Zhao, Hong Zong, Pingping Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
An overview of kinase downregulators and recent advances in discovery approaches
Beilei Wang, Hong Wu, Chen Hu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 52
Beilei Wang, Hong Wu, Chen Hu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 52
DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis
Jee‐Heun Kim, So‐Yeon Park, So-El Jeon, et al.
Theranostics (2022) Vol. 12, Iss. 12, pp. 5258-5271
Open Access | Times Cited: 24
Jee‐Heun Kim, So‐Yeon Park, So-El Jeon, et al.
Theranostics (2022) Vol. 12, Iss. 12, pp. 5258-5271
Open Access | Times Cited: 24
Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma
Lianxin Hu, Yanfeng Zhang, Lei Guo, et al.
Molecular Cell (2024) Vol. 84, Iss. 4, pp. 776-790.e5
Closed Access | Times Cited: 5
Lianxin Hu, Yanfeng Zhang, Lei Guo, et al.
Molecular Cell (2024) Vol. 84, Iss. 4, pp. 776-790.e5
Closed Access | Times Cited: 5
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment
Zhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3801-3801
Open Access | Times Cited: 37
Zhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3801-3801
Open Access | Times Cited: 37
Autoregulatory control of microtubule binding in doublecortin-like kinase 1
Regina L. Agulto, Melissa M Rogers, Tracy Tan, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 30
Regina L. Agulto, Melissa M Rogers, Tracy Tan, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 30
Pleiotropic effects of DCLK1 in cancer and cancer stem cells
Dibyashree Chhetri, Srinivasan Vengadassalapathy, Santhosh Venkadassalapathy, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 20
Dibyashree Chhetri, Srinivasan Vengadassalapathy, Santhosh Venkadassalapathy, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 20
Targeting DCLK1 overcomes 5‐fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β‐catenin pathway‐mediated cancer stemness
Lanqing Wang, Lei Zhao, Zhenyu Lin, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 19
Lanqing Wang, Lei Zhao, Zhenyu Lin, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 19
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival
Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 10
Open Access | Times Cited: 19
Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 10
Open Access | Times Cited: 19
Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway
Bin Yang, Yunjie Zhao, Wu Luo, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 12
Bin Yang, Yunjie Zhao, Wu Luo, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 12
Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer
Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Cancer Letters (2023) Vol. 578, pp. 216437-216437
Open Access | Times Cited: 12
Samrita Dogra, Sugantha Priya Elayapillai, Dongfeng Qu, et al.
Cancer Letters (2023) Vol. 578, pp. 216437-216437
Open Access | Times Cited: 12
Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1
Onisha Patel, Michael J. Roy, Ashleigh Kropp, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 26
Onisha Patel, Michael J. Roy, Ashleigh Kropp, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 26
Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
Ling Ding, Yuning Yang, Yang Ge, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5729-5729
Open Access | Times Cited: 24
Ling Ding, Yuning Yang, Yang Ge, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5729-5729
Open Access | Times Cited: 24
DCLK1 autoinhibition and activation in tumorigenesis
Linna Cheng, Zejing Yang, Wenhao Guo, et al.
The Innovation (2021) Vol. 3, Iss. 1, pp. 100191-100191
Open Access | Times Cited: 24
Linna Cheng, Zejing Yang, Wenhao Guo, et al.
The Innovation (2021) Vol. 3, Iss. 1, pp. 100191-100191
Open Access | Times Cited: 24
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
Yang Ge, Heshu Liu, Yuanyuan Zhang, et al.
Translational Oncology (2022) Vol. 17, pp. 101317-101317
Open Access | Times Cited: 18
Yang Ge, Heshu Liu, Yuanyuan Zhang, et al.
Translational Oncology (2022) Vol. 17, pp. 101317-101317
Open Access | Times Cited: 18
Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1/Akt/NF-κB pathway
Tianjiao Lai, Haifeng Qiu, Lulu Si, et al.
Cell Cycle (2022) Vol. 21, Iss. 15, pp. 1599-1618
Open Access | Times Cited: 17
Tianjiao Lai, Haifeng Qiu, Lulu Si, et al.
Cell Cycle (2022) Vol. 21, Iss. 15, pp. 1599-1618
Open Access | Times Cited: 17
Intestinal Tuft Cells: Morphology, Function, and Implications for Human Health
Jennifer B. Silverman, Paige N. Vega, Matthew J. Tyska, et al.
Annual Review of Physiology (2023) Vol. 86, Iss. 1, pp. 479-504
Open Access | Times Cited: 10
Jennifer B. Silverman, Paige N. Vega, Matthew J. Tyska, et al.
Annual Review of Physiology (2023) Vol. 86, Iss. 1, pp. 479-504
Open Access | Times Cited: 10